Cipher Pharmaceuticals Inc. (TSE:CPH – Free Report) (NASDAQ:CPHR) – Stock analysts at Stifel Canada raised their Q4 2025 earnings estimates for shares of Cipher Pharmaceuticals in a report issued on Thursday, October 16th. Stifel Canada analyst J. Keywood now anticipates that the company will post earnings of $0.28 per share for the quarter, up from their previous forecast of $0.27. The consensus estimate for Cipher Pharmaceuticals’ current full-year earnings is $1.29 per share.
Cipher Pharmaceuticals Stock Performance
TSE:CPH opened at C$14.93 on Monday. The company has a fifty day moving average of C$15.47 and a 200-day moving average of C$13.67. The firm has a market capitalization of C$379.13 million, a P/E ratio of 32.46 and a beta of 0.77. The company has a quick ratio of 2.67, a current ratio of 2.00 and a debt-to-equity ratio of 41.22. Cipher Pharmaceuticals has a twelve month low of C$10.61 and a twelve month high of C$17.50.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.
Featured Stories
- Five stocks we like better than Cipher Pharmaceuticals
- How to Most Effectively Use the MarketBeat Earnings Screener
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- The 3 Best Blue-Chip Stocks to Buy Now
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- What is a Microcap Stock? Everything You Need to Know
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
